Arteris, Inc. (NASDAQ:AIP – Get Free Report) Director Saiyed Atiq Raza sold 73,610 shares of the stock in a transaction dated Thursday, February 26th. The shares were sold at an average price of $17.14, for a total transaction of $1,261,675.40. Following the transaction, the director owned 511,483 shares of the company’s stock, valued at approximately $8,766,818.62. The trade was a 12.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Saiyed Atiq Raza also recently made the following trade(s):
- On Friday, February 27th, Saiyed Atiq Raza sold 11,762 shares of Arteris stock. The stock was sold at an average price of $17.01, for a total transaction of $200,071.62.
- On Wednesday, February 25th, Saiyed Atiq Raza sold 4,907 shares of Arteris stock. The shares were sold at an average price of $17.00, for a total transaction of $83,419.00.
Arteris Trading Down 1.3%
Shares of NASDAQ:AIP traded down $0.23 during mid-day trading on Friday, reaching $16.99. The company had a trading volume of 519,469 shares, compared to its average volume of 485,938. Arteris, Inc. has a one year low of $5.46 and a one year high of $19.85. The company’s 50-day moving average price is $15.86 and its 200-day moving average price is $13.59. The firm has a market cap of $772.54 million, a price-to-earnings ratio of -20.72 and a beta of 1.47.
Analysts Set New Price Targets
A number of analysts recently commented on AIP shares. Northland Securities set a $24.00 price target on shares of Arteris in a research note on Friday, February 13th. Rosenblatt Securities restated a “buy” rating and set a $20.00 target price on shares of Arteris in a research report on Friday, February 13th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a report on Wednesday, January 21st. Finally, TD Cowen reiterated a “buy” rating on shares of Arteris in a research note on Wednesday, November 5th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $20.17.
Check Out Our Latest Stock Report on Arteris
Institutional Trading of Arteris
Several institutional investors and hedge funds have recently modified their holdings of the business. Invesco Ltd. grew its holdings in shares of Arteris by 28.0% during the fourth quarter. Invesco Ltd. now owns 17,499 shares of the company’s stock worth $271,000 after purchasing an additional 3,830 shares in the last quarter. Mercer Global Advisors Inc. ADV bought a new stake in Arteris during the fourth quarter valued at approximately $162,000. VestGen Advisors LLC purchased a new position in Arteris in the 4th quarter worth approximately $218,000. Tudor Investment Corp ET AL purchased a new position in Arteris in the 4th quarter worth approximately $2,473,000. Finally, Numerai GP LLC bought a new position in shares of Arteris in the 4th quarter worth $390,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.
About Arteris
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Featured Articles
- Five stocks we like better than Arteris
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
